Title: BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman
Author: Hagens Berman Sobol Shapiro LLP
Source: newsapi
Published: 2024-12-12T23:34:00Z
URL: https://www.globenewswire.com/news-release/2024/12/12/2996582/32716/en/BioAge-Labs-BIOA-Azelaprag-Trial-Halt-Raises-Questions-About-Pre-IPO-Disclosures-Hagens-Berman.html
----------------------------------------
SAN FRANCISCO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling an… [+2655 chars]